CLINICAL_TRIALS
trial_result
· 2015-12-16
Clinical Trial Update: Simvastatin in Waldenstrom's Macroglobulinemia [Phase 2]
Summary
A Phase 2 clinical trial of simvastatin for Waldenström's macroglobulinemia was terminated, with results posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Dana-Farber Cancer Institute | Conditions: Waldenstrom's Macroglobulinemia | Phase 2 | Status: TERMINATED | Results posted: 2015-12-16